BioTech CELU

Celularity Faces Nasdaq Compliance Issue Over Delayed 10-Q Filings

(RTTNews) - Celularity Inc. (CELU) announced on Tuesday that it received a Nasdaq notification on August 21, 2026, regarding non-compliance with Listing Rule 5250(c)(1) due to delayed 10-Q filings.

The delayed filings cover the quarters ended March 31 and June 30, 2026.

Nasdaq requested that Celularity submit a compliance plan by September 4, 2026. Any exception granted may extend until November 16, 2026.

Celularity said the notification does not immediately affect the listing or trading of its common stock on the Nasdaq Capital Market, which continues to trade under the ticker "CELU."

The company said it is working to complete and file both 10-Q reports as soon as practicable.

CELU closed Tuesday at $0.80, up 6.92%. In the after-hours trading, the stock is up 1.40% at $0.81.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available